The DOI matches its Crossref record.
Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression
Open accessAbstract
Summary: Interleukin (IL)‐21 is a novel cytokine that has been shown to enhance proliferation and activation of CD8+ T cells, enhance natural killer (NK) cell activity and costimulate anti‐CD40‐driven B‐cell proliferation in mice. Several studies have furthermore demonstrated antitumour effects of IL‐21 administration in mouse models. In this study we have investigated how IL‐21 affects the survival and cytotoxicity of human NK cells and modulates their expression of surface receptors and of the effector molecules granzyme B and perforin. In contrast to murine NK cells, where IL‐21 alone cannot sustain survival, IL‐21 and IL‐2 were equally efficient in sustaining survival of human NK cells. In the absence of other cytokines, IL‐21 had little effect on expression of a panel of surface receptors on human NK cells. However, IL‐21 synergized with IL‐2 to up‐regulate several surface receptors, including NKG2A, CD25, CD86 and CD69. The CD25+ CD86+ NK cells were CD56 bright and were large and granular. Expression of the effector molecules perforin and granzyme A and B was up‐regulated by IL‐21 at both mRNA and protein levels. Furthermore, IL‐21 increased the cytotoxicity of NK cells against K562 target cells. These findings suggest that IL‐21 modulates NK cell activity through induction of intracellular effector molecules as well as modulation of surface receptor expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Denman, C. J., Senyukov, V. V., Somanchi, S. S., Phatarpekar, P. V., Kopp, L. M., Johnson, J. L., Singh, H., Hurton, L., Maiti, S. N., Huls, M. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030264 · Cited by 683
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Bald, T., Krummel, M. F., Smyth, M. J., & Barry, K. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0728-z · Cited by 506
The role of cytokines in the regulation of NK cells in the tumor environment
Konjević, G. M., Vuletić, A. M., Mirjačić Martinović, K. M., Larsen, A. K., & Jurišić, V. B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.001 · Cited by 279
Developmental and Functional Control of Natural Killer Cells by Cytokines
Wu, Y., Tian, Z., & Wei, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00930 · Cited by 269
Metadata
- Authors
- Skak, K., Frederiksen, K. S., & Lundsgaard, D.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2008-01-09
- Volume
- 123
- Issue
- 4
- Pages
- 575-583
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W1992347525
- Cited by
- 165
- References
- 0
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression. https://app.cochat.ai/papers/10.1111/j.1365-2567.2007.02730.x
- The paper
- Skak, K., Frederiksen, K. S., & Lundsgaard, D. (2008). Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression. Immunology. https://doi.org/10.1111/j.1365-2567.2007.02730.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.